Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Tung Huei Lin"'
Autor:
Rabindranath Bera, Ming-Chun Chiu, Ying-Jung Huang, Tung-Huei Lin, Ming-Chung Kuo, Lee-Yung Shih
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-18 (2019)
Abstract Background Additional sex combs-like 1 (ASXL1) mutations have been described in all forms of myeloid neoplasms including chronic myelomonocytic leukemia (CMML) and associated with inferior outcomes, yet the molecular pathogenesis of ASXL1 mu
Externí odkaz:
https://doaj.org/article/133b1099db0a4f9ea3599d81b73d5774
Autor:
Ming-Chung Kuo, Wen-Yu Chuang, Hung Chang, Tung-Huei Lin, Jin-Hou Wu, Tung-Liang Lin, Che-Wei Ou, Yu-Shin Hung, Ting-Yu Huang, Ying-Jung Huang, Po-Nan Wang, Lee-Yung Shih
Publikováno v:
American Journal of Clinical Pathology. 159:474-483
Objectives The clinical presentations of essential thrombocythemia (ET) may be quite similar to early/prefibrotic primary myelofibrosis (pre-PMF), especially in pre-PMF presenting with thrombocytosis (pre–PMF-T), but may be associated with a differ
Autor:
Hsi-Che Liu, Ming-Chung Kuo, Kang-Hsi Wu, Tsai-Yun Chen, Jiann-Shiuh Chen, Ming-Chung Wang, Tung-Liang Lin, YoungSen Yang, Ming-Chun Ma, Po-Nan Wang, Jiunn-Ming Sheen, Shih-Chung Wang, Shih-Hsiang Chen, Tang-Her Jaing, Chao-Neng Cheng, Ting-Chi Yeh, Tung-Huei Lin, Lee-Yung Shih
Publikováno v:
British Journal of Cancer. 128:1294-1300
Autor:
Yi‐Jiun Su, Ming‐Chung Kuo, Tsai‐Yun Chen, Ming‐Chung Wang, Youngsen Yang, Ming‐Chun Ma, Tung‐Liang Lin, Tung‐Huei Lin, Hung Chang, Chieh‐Lin Jerry Teng, Pei‐Ching Hsiao, Chih‐Cheng Chen, Po‐Nan Wang, Lee‐Yung Shih
Publikováno v:
Cancer Science. 113:3518-3527
Several studies have compared the molecular responses between e14a2 and e13a2 BCR::ABL1 transcripts in chronic myeloid leukemia (CML) patients treated with front-line imatinib, but there were very limited studies on nilotinib or dasatinib-treated pat
Autor:
Der-Cherng Liang, Ming-Chun Chiu, Tung-Huei Lin, Yu-Shu Shih, Chein-Fuang Huang, Ming-Chung Kuo, Ying-Jung Huang, Sung-Tzu Liang, Lee-Yung Shih, Shu-Chun Tsai
Supplementary Figure S1 and Tables S1-3. Figure S1. Frequencies and distribution of co-operating mutations in RUNX1 mutationpositive patients. Table S1. Comparison of clinicohematological characteristics according to the biological activities of RUNX
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27e6ea4418272604a22f5910130ebe7e
https://doi.org/10.1158/1078-0432.22455140.v1
https://doi.org/10.1158/1078-0432.22455140.v1
Autor:
Der-Cherng Liang, Ming-Chun Chiu, Tung-Huei Lin, Yu-Shu Shih, Chein-Fuang Huang, Ming-Chung Kuo, Ying-Jung Huang, Sung-Tzu Liang, Lee-Yung Shih, Shu-Chun Tsai
Purpose: Transcription factor RUNX1 is essential for normal hematopoiesis. High mutation frequencies of RUNX1 gene in chronic myelomonocytic leukemia (CMML) and myelodysplastic syndromes (MDS) have been described, whereas the biologic significances o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fd03bb25b98934bd954dbbef9f9399c
https://doi.org/10.1158/1078-0432.c.6522935.v1
https://doi.org/10.1158/1078-0432.c.6522935.v1
Autor:
Hsiao-Wen Kao, Der-Cherng Liang, Jin-Hou Wu, Ming-Chung Kuo, Po-Nan Wang, Chao-Ping Yang, Yu-Shu Shih, Tung-Huei Lin, Yu-Hui Huang, Lee-Yung Shih
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 6, Pp 481-488 (2014)
Minimally differentiated acute myeloid leukemia (AML-M0) is a rare subtype of AML with poor prognosis. Although genetic alterations are increasingly reported in AML, the gene mutations have not been comprehensively studied in AML-M0. We aimed to exam
Externí odkaz:
https://doaj.org/article/a937f8574a3a4612af6fec7fb555354d
Autor:
Ying Jung Huang, Ming Chung Kuo, Lee Yung Shih, Rabindranath Bera, Tung Huei Lin, Ming Chun Chiu
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-18 (2019)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Background Additional sex combs-like 1 (ASXL1) mutations have been described in all forms of myeloid neoplasms including chronic myelomonocytic leukemia (CMML) and associated with inferior outcomes, yet the molecular pathogenesis of ASXL1 mutations (
Autor:
Tung-Liang Lin, Yasunobu Nagata, Hsiao-Wen Kao, Masashi Sanada, Yusuke Okuno, Chein-Fuang Huang, Der-Cherng Liang, Ming-Chung Kuo, Chang-Liang Lai, En-Hui Lee, Yu-Shu Shih, Hiroko Tanaka, Yuichi Shiraishi, Kenichi Chiba, Tung-Huei Lin, Jin-Hou Wu, Satoru Miyano, Seishi Ogawa, Lee-Yung Shih
Publikováno v:
Haematologica, Vol 99, Iss 1 (2014)
Somatic mutations of TET2, IDH1, and IDH2 have been described in myelodysplastic syndrome. The impact of these mutations on outcome of myelodysplastic syndrome and their progression to secondary acute myeloid leukemia remains unclear. Mutation status
Externí odkaz:
https://doaj.org/article/d53cabcadf364b7ab452678d42049b06
Autor:
Tung-Huei Lin, Chien-Feng Sun, Ting-Yu Huang, Ming-Chung Kuo, Lee-Yung Shih, Tung-Liang Lin, Hung Chang, Po-Nan Wang, Ying-Jung Huang, Jin-Hou Wu
Publikováno v:
Journal of Clinical Pathology. 71:514-521
AimsWe investigated the clinical and prognostic relevance of the mutational status of driver genes with allele burden and endogenous erythroid colony (EEC) growth in 203 Taiwanese patients with primary myelofibrosis (PMF).MethodsPyrosequencing was us